Qube Research & Technologies (QRT)
BCAB icon

Qube Research & Technologies (QRT)’s BioAtla BCAB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-586
Closed -$51.6K – 3461
2024
Q3 		$51.6K Buy
586
+42
+8% +$3.52K ﹤0.01% 2854
2024
Q2 		$37.3K Buy
+544
New +$64.7K ﹤0.01% 2796
2023
Q2 		– Sell
-374
Closed -$50.1K – 2399
2023
Q1 		$50.1K Sell
374
-1,513
-80% -$273K ﹤0.01% 2227
2022
Q4 		$778K Buy
1,887
+1,648
+690% +$684K ﹤0.01% 1326
2022
Q3 		$92K Sell
239
-68
-22% -$22.3K ﹤0.01% 1994
2022
Q2 		$44K Sell
307
-52
-14% -$8.28K ﹤0.01% 2147
2022
Q1 		$90K Sell
359
-341
-49% -$143K ﹤0.01% 2092
2021
Q4 		$687K Buy
+700
New +$895K 0.01% 1400
2021
Q1 		– Sell
-148
Closed -$252K – 1912
2020
Q4 		$252K Buy
+148
New +$247K ﹤0.01% 1431

Other funds holding BCAB

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BCAB Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 586 shares — an estimated $51.6K sold.

Qube Research & Technologies (QRT) first reported a position in BCAB in Q4 2020 and held it in 9 quarters. The position peaked at $778K in Q4 2022. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 586 BioAtla shares in Q4 2024, an estimated $51.6K.
  • Qube Research & Technologies (QRT) first reported a position in BioAtla in Q4 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s BioAtla position peaked at $778K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.